| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.949 | 6.233 | 15.416 | 774 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 4.949 | 6.233 | 15.416 | 774 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 4.400 | 5.398 | 9.580 | 574 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 550 | 835 | 5.837 | 200 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 401 | 648 | 5.374 | 177 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dumont Medtech Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 991 | 2.034 | 7.559 | 3.383 | 3.317 | 3.254 | 3.182 | 3.192 | 3.182 | 3.165 |
| Inventories | 988 | 2.017 | 2.617 | 3.312 | 3.248 | 3.186 | 3.115 | 3.125 | 3.116 | 3.098 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 4 | 17 | 4.942 | 71 | 70 | 68 | 67 | 67 | 67 | 67 |
| Shareholders Funds | 587 | 895 | 6.254 | 3.243 | 3.180 | 3.120 | 3.051 | 3.060 | 3.051 | 3.034 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 405 | 1.140 | 1.305 | 140 | 137 | 134 | 131 | 132 | 131 | 131 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Dumont Medtech Srl